← All State Street CORP filings

State Street CORP Schedule 13G passive stakes

NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Stake in Netstreit Corp
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.3% of Netstreit Corp's common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5% Stake in NETSCOUT Systems
State Street Corporation has reported beneficial ownership of 5% of NETSCOUT Systems Inc. common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.3% Stake in NBT Bancorp
State Street Corporation has disclosed beneficial ownership of 5.3% of NBT Bancorp Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.6% Stake in National Health Investors
State Street Corporation has updated its beneficial ownership filing for National Health Investors Inc., now holding 5.6% of the company's common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.2% Stake in National Bank Holdings
State Street Corporation has reported beneficial ownership of 5.2% of National Bank Holdings Corp. common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.3% Stake in Myriad Genetics
State Street Corporation has disclosed beneficial ownership of 5.3% of Myriad Genetics Inc. common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Stake in McEwen Inc.
State Street Corporation and its affiliate SSGA Funds Management, Inc. have filed a Schedule 13G, reporting beneficial ownership of 7.1% and 5.5% respectively, of McEwen Inc.'s common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses McDonald's Stake
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.1% of McDonald's Corporation common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 4.8% Stake in MaxLinear
State Street Corporation has reported a beneficial ownership of 4.8% in MaxLinear Inc. common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.3% Stake in Masco Corp
State Street Corporation has reported beneficial ownership of 5.3% of Masco Corp's common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Corp Discloses 5.2% Stake in Martin Marietta
State Street Corporation has reported beneficial ownership of 5.2% of Martin Marietta Materials Inc. common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses M/I Homes Stake
State Street Corporation has updated its beneficial ownership filing for M/I Homes Inc., reporting a 5.2% stake as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Corp Discloses 4.8% Stake in Live Nation
State Street Corporation has reported beneficial ownership of 11,396,416 shares, representing 4.8% of the outstanding common stock of Live Nation Entertainment Inc.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Lightbridge Corp Stake
State Street Corporation and SSGA Funds Management, Inc. have updated their beneficial ownership filings for Lightbridge Corp, reporting a combined stake.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.5% Stake in Lexeo Therapeutics
State Street Corporation has disclosed a beneficial ownership of 5.5% in Lexeo Therapeutics Inc. as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Kopin Corp Stake
State Street Corporation and its affiliate SSGA Funds Management, Inc. have reported beneficial ownership of Kopin Corp common stock, holding a combined 9.4% stake.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Stake in Ironwood Pharma
State Street Corporation has updated its beneficial ownership filing for Ironwood Pharmaceuticals Inc., reporting a significant stake.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.5% Stake in Iovance Biotherapeutics
State Street Corporation has reported a beneficial ownership of 5.5% in Iovance Biotherapeutics Inc. through a Schedule 13G filing.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5% Stake in Inventrust Properties
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5% of Inventrust Properties Corp. common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 6.8% Stake in Intellia Therapeutics
State Street Corporation has disclosed beneficial ownership of 6.8% of Intellia Therapeutics' common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Indie Semiconductor Stake
State Street Corporation and SSGA Funds Management, Inc. have updated their beneficial ownership filings for Indie Semiconductor Inc., reporting a combined stake.
NYSE
STT
State Street CORP
SCHEDULE: State Street Corp Discloses Impinj Stake
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.6% of Impinj Inc. common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Stake in Hycroft Mining
State Street Corporation and its affiliate SSGA Funds Management, Inc. have reported a combined beneficial ownership of 6.9% in Hycroft Mining Holding Corp. as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports Honeywell Stake
State Street Corporation has updated its beneficial ownership filing for Honeywell International Inc., reporting a significant stake.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Hecla Mining Stake
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5% of Hecla Mining Company's common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports Stake in Healthpeak Properties
State Street Corporation has updated its Schedule 13G filing, reporting beneficial ownership of 6.4% of Healthpeak Properties Inc. common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Hawkins Inc. Stake
State Street Corporation has reported beneficial ownership of 5.1% of Hawkins Inc. common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.5% Stake in Gulfport Energy
State Street Corporation has disclosed beneficial ownership of 5.5% of Gulfport Energy Corp.'s common stock, holding 990,939 shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Corp. Reports Stake in Green Plains Inc.
State Street Corporation has updated its beneficial ownership filing for Green Plains Inc., reporting a 5.4% stake as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.6% Stake in GRAIL Inc.
State Street Corporation has disclosed beneficial ownership of 5.6% of GRAIL Inc.'s common stock as of June 30, 2026.